Home › NDC Lookup › RxCUI directory › RxCUI 1747579

Venetoclax 50 MG Oral Tablet [Venclexta] — RxCUI 1747579

RxNorm drug concept · Semantic branded drug
RxCUI 1747579 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1747579
Official nameVenetoclax 50 MG Oral Tablet [Venclexta]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVenclexta 50 MG Oral Tablet
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)2,880 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Venetoclax: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in adults. It is also used with azacitidine, decitabine, or low-dose cytarabine for newly diagnose...
  • Take Venclexta tablets by mouth once a day with a meal and water. Your dose starts low and goes up gradually. Follow your prescriber's schedule exactly.
  • Venetoclax can kill cancer cells fast and cause tumor lysis syndrome, which can harm the kidneys. A slow ramp-up, hydration, and preventive medicines help lower that risk.
  • Common ones include low blood counts, diarrhea, nausea, fatigue, swelling, cough, and muscle or bone pain. Call your care team right away for fever or signs of infection, or if you...
📖 Read our full Venetoclax guide →

🕸️ Concept Web — How Venetoclax 50 MG Oral Tablet [Venclexta] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Venetoclax 50 MG Oral Tablet [Venclexta] RxCUI 1747579

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Venetoclax 1747556
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Venclexta 1747562
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Venetoclax Oral Tablet 1747560
    • Venetoclax Oral Product 1747558
    • Venetoclax Pill 1747559
    • Venetoclax Oral Tablet [Venclexta] 1747564
    • Venclexta Oral Product 1747565
    • Venclexta Pill 1747566
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 1747579 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00074-0561-11 1 BLISTER PACK in 1 CARTON (0074-0561-11) / 2 TABLET, FILM... Venclexta AbbVie Inc. 2016-04-11
00074-0561-14 1 BLISTER PACK in 1 CARTON (0074-0561-14) / 14 TABLET, FILM... Venclexta AbbVie Inc. 2016-04-11
00074-0566-07 1 BLISTER PACK in 1 CARTON (0074-0566-07) / 7 TABLET, FILM... Venclexta AbbVie Inc. 2016-04-11
00074-0566-11 1 BLISTER PACK in 1 CARTON (0074-0566-11) / 1 TABLET, FILM... Venclexta AbbVie Inc. 2016-04-11
00074-0576-11 1 BLISTER PACK in 1 CARTON (0074-0576-11) / 1 TABLET, FILM... Venclexta AbbVie Inc. 2016-04-11
00074-0576-22 120 TABLET, FILM COATED in 1 BOTTLE (0074-0576-22) Venclexta AbbVie Inc. 2016-04-11
00074-0576-30 1 BOTTLE in 1 CARTON (0074-0576-30) / 28 TABLET, FILM COATE... Venclexta AbbVie Inc. 2022-06-15
00074-0579-28 1 KIT in 1 CARTON (0074-0579-28) * 7 TABLET, FILM COATED i... Venclexta AbbVie Inc. 2016-04-11
Observed labelers: AbbVie Inc. (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.